1. Shi, Fujie, Wu, Yunfei, Wang, Kai, Liu, Minghui, Sun, Xinlei. 2023. A pancancer analysis of the oncogenic role of ZNRF2 in human tumours. In Journal of cellular and molecular medicine, 27, 3296-3312. doi:10.1111/jcmm.17900. https://pubmed.ncbi.nlm.nih.gov/37551845/
2. Hoxhaj, Gerta, Najafov, Ayaz, Toth, Rachel, Prescott, Alan R, MacKintosh, Carol. 2012. ZNRF2 is released from membranes by growth factors and, together with ZNRF1, regulates the Na+/K+ATPase. In Journal of cell science, 125, 4662-75. doi:10.1242/jcs.110296. https://pubmed.ncbi.nlm.nih.gov/22797923/
3. Liu, Jin-Tao, Sun, Zhen-Xuan, Zhong, Rui, Zhang, Lei, Chen, Bo. 2023. ZNRF2 as an oncogene is transcriptionally regulated by CREB1 in breast cancer models. In Human cell, 36, 1501-1515. doi:10.1007/s13577-023-00913-7. https://pubmed.ncbi.nlm.nih.gov/37165255/
4. Hoxhaj, Gerta, Caddye, Edward, Najafov, Ayaz, Prescott, Alan R, MacKintosh, Carol. 2016. The E3 ubiquitin ligase ZNRF2 is a substrate of mTORC1 and regulates its activation by amino acids. In eLife, 5, . doi:10.7554/eLife.12278. https://pubmed.ncbi.nlm.nih.gov/27244671/
5. Xiao, Qiang, Yang, Yu, An, Qing, Qi, Yong. . MicroRNA-100 suppresses human osteosarcoma cell proliferation and chemo-resistance via ZNRF2. In Oncotarget, 8, 34678-34686. doi:10.18632/oncotarget.16149. https://pubmed.ncbi.nlm.nih.gov/28416774/
6. Yang, Meiqin, Zhai, Zhensheng, Zhang, Yunfeng, Wang, Yue. 2019. Clinical significance and oncogene function of long noncoding RNA HAGLROS overexpression in ovarian cancer. In Archives of gynecology and obstetrics, 300, 703-710. doi:10.1007/s00404-019-05218-5. https://pubmed.ncbi.nlm.nih.gov/31197441/
智鼠故事 
